Psychiatric Genomics
portes grátis
Psychiatric Genomics
Patrinos, George P.; Alda, Martin; Tsermpini, Evangelia Eirini
Elsevier Science Publishing Co Inc
03/2022
418
Mole
Inglês
9780128196021
15 a 20 dias
450
Descrição não disponível.
1. Genomics and psychiatry: a historical overview
2. Schizophrenia genomics
3. Genetics of bipolar disorder
4. Genetics of depression
5. Genetics of personality disorders
6. Genomics and epigenomics of anxiety and obsessive-compulsive disorders
7. Neurogenetics of alcohol use disorder a subset of reward deficiency syndrome: candidate genes to be or not to be?
8. Pharmacogenomics and antipsychotics: efficacy and adverse drug reactions
9. Pharmacogenomics and antidepressants: efficacy and adverse drug reactions
10. Pharmacogenomics and mood stabilizers: efficacy and adverse drug reactions
11. Balancing prevention and respect: the ethical stakes of a psychiatric genomics lens for mental disorder and intellectual disability
12. Genetic animal models for psychiatric disorders
13. Psychiatric genomics: brain pathophysiology and genetic factors
14. Integration with systems biology approaches and -omics data to characterize risk variation
15. Usage of biobank data for psychiatric genomics and promotion of precision psychiatry
16. Shared heritability among psychiatric disorders and traits
17. Endophenotypes in psychiatric genomics: a selective review of their status and a call to action
2. Schizophrenia genomics
3. Genetics of bipolar disorder
4. Genetics of depression
5. Genetics of personality disorders
6. Genomics and epigenomics of anxiety and obsessive-compulsive disorders
7. Neurogenetics of alcohol use disorder a subset of reward deficiency syndrome: candidate genes to be or not to be?
8. Pharmacogenomics and antipsychotics: efficacy and adverse drug reactions
9. Pharmacogenomics and antidepressants: efficacy and adverse drug reactions
10. Pharmacogenomics and mood stabilizers: efficacy and adverse drug reactions
11. Balancing prevention and respect: the ethical stakes of a psychiatric genomics lens for mental disorder and intellectual disability
12. Genetic animal models for psychiatric disorders
13. Psychiatric genomics: brain pathophysiology and genetic factors
14. Integration with systems biology approaches and -omics data to characterize risk variation
15. Usage of biobank data for psychiatric genomics and promotion of precision psychiatry
16. Shared heritability among psychiatric disorders and traits
17. Endophenotypes in psychiatric genomics: a selective review of their status and a call to action
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
?Adverse drug reactions; Affective disorders; Alcohol use disorder (AUD); Algorithmic phenotyping; Annotation; Antidepressants; Antipsychotics; Antisocial; Anxiety disorders; Association Studies; Biobanks; Bipolar disorder; Borderline personality disorder; Brain pathophysiology; Brain-derived neurotrophic factor; Candidate Genes; Carbamazepine; Colocalization; Common genetic variants; Corticotrophin-releasing hormone receptor; DNA-methylation; Depression subtypes; Disability studies; Dopamine homeostasis; Drug metabolism; Efficacy; Electronic health records; Embodied irrationality; Endophenotype; Ethics; Eugenics; Family studies; Forward genetics; GWAS; GWAS analysis; Genetic addiction risk score (GARS); Genetic architecture; Genetic correlation; Genetic engineering; Genetic epidemiology; Genetic factors; Genetic overlap; Genetic susceptibility; Genome wide association studies; Genome-wide association study; Genomics; Genotype; Guidelines; History; Hypodopaminergia; Hypothalamic-pituitary-adrenocortical axis; Lamotrigine; Linkage Studies; Lithium; Major depressive disorder; Medical informatics; Mendelian randomization; Mental impairment; Molecular genetics; Mood disorders; Mouse model; Network; Obsessive Compulsive Disorder; Oxytocin; Pathway; Personalized medicine; Pharmacogenetics; Pharmacogenomics; Phenome-wide association study; Pleiotropy; Polygenic risk; Polygenic risk score; Polygenic risk scores; Precision medicine; Prodopamine regulation; Psychiatric disorders; Psychiatric genetics; Psychiatric genomics; Psychopathology; Psychophysiology; QTL; RDoC; Research ethics; Reward deficiency syndrome (RDS); SLC6A4; Schizophrenia; Scientific racism; Sequencing; Social model; Statistical genetic; Suffering; TWAS; Therapygenetics; Toxicity; Transdiagnostic; Transgene; Twin studies; Valproate; Whole genome sequencing
1. Genomics and psychiatry: a historical overview
2. Schizophrenia genomics
3. Genetics of bipolar disorder
4. Genetics of depression
5. Genetics of personality disorders
6. Genomics and epigenomics of anxiety and obsessive-compulsive disorders
7. Neurogenetics of alcohol use disorder a subset of reward deficiency syndrome: candidate genes to be or not to be?
8. Pharmacogenomics and antipsychotics: efficacy and adverse drug reactions
9. Pharmacogenomics and antidepressants: efficacy and adverse drug reactions
10. Pharmacogenomics and mood stabilizers: efficacy and adverse drug reactions
11. Balancing prevention and respect: the ethical stakes of a psychiatric genomics lens for mental disorder and intellectual disability
12. Genetic animal models for psychiatric disorders
13. Psychiatric genomics: brain pathophysiology and genetic factors
14. Integration with systems biology approaches and -omics data to characterize risk variation
15. Usage of biobank data for psychiatric genomics and promotion of precision psychiatry
16. Shared heritability among psychiatric disorders and traits
17. Endophenotypes in psychiatric genomics: a selective review of their status and a call to action
2. Schizophrenia genomics
3. Genetics of bipolar disorder
4. Genetics of depression
5. Genetics of personality disorders
6. Genomics and epigenomics of anxiety and obsessive-compulsive disorders
7. Neurogenetics of alcohol use disorder a subset of reward deficiency syndrome: candidate genes to be or not to be?
8. Pharmacogenomics and antipsychotics: efficacy and adverse drug reactions
9. Pharmacogenomics and antidepressants: efficacy and adverse drug reactions
10. Pharmacogenomics and mood stabilizers: efficacy and adverse drug reactions
11. Balancing prevention and respect: the ethical stakes of a psychiatric genomics lens for mental disorder and intellectual disability
12. Genetic animal models for psychiatric disorders
13. Psychiatric genomics: brain pathophysiology and genetic factors
14. Integration with systems biology approaches and -omics data to characterize risk variation
15. Usage of biobank data for psychiatric genomics and promotion of precision psychiatry
16. Shared heritability among psychiatric disorders and traits
17. Endophenotypes in psychiatric genomics: a selective review of their status and a call to action
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
?Adverse drug reactions; Affective disorders; Alcohol use disorder (AUD); Algorithmic phenotyping; Annotation; Antidepressants; Antipsychotics; Antisocial; Anxiety disorders; Association Studies; Biobanks; Bipolar disorder; Borderline personality disorder; Brain pathophysiology; Brain-derived neurotrophic factor; Candidate Genes; Carbamazepine; Colocalization; Common genetic variants; Corticotrophin-releasing hormone receptor; DNA-methylation; Depression subtypes; Disability studies; Dopamine homeostasis; Drug metabolism; Efficacy; Electronic health records; Embodied irrationality; Endophenotype; Ethics; Eugenics; Family studies; Forward genetics; GWAS; GWAS analysis; Genetic addiction risk score (GARS); Genetic architecture; Genetic correlation; Genetic engineering; Genetic epidemiology; Genetic factors; Genetic overlap; Genetic susceptibility; Genome wide association studies; Genome-wide association study; Genomics; Genotype; Guidelines; History; Hypodopaminergia; Hypothalamic-pituitary-adrenocortical axis; Lamotrigine; Linkage Studies; Lithium; Major depressive disorder; Medical informatics; Mendelian randomization; Mental impairment; Molecular genetics; Mood disorders; Mouse model; Network; Obsessive Compulsive Disorder; Oxytocin; Pathway; Personalized medicine; Pharmacogenetics; Pharmacogenomics; Phenome-wide association study; Pleiotropy; Polygenic risk; Polygenic risk score; Polygenic risk scores; Precision medicine; Prodopamine regulation; Psychiatric disorders; Psychiatric genetics; Psychiatric genomics; Psychopathology; Psychophysiology; QTL; RDoC; Research ethics; Reward deficiency syndrome (RDS); SLC6A4; Schizophrenia; Scientific racism; Sequencing; Social model; Statistical genetic; Suffering; TWAS; Therapygenetics; Toxicity; Transdiagnostic; Transgene; Twin studies; Valproate; Whole genome sequencing
